Alcoholism
Alcoholism
Alcoholism
3. What is the mechanism behind the development of hepatic coma in liver cirrhosis?
- Hepatic encephalopathy is the impairment of brain function as a result of liver cirrhosis.
This impairment affects behavior, mood, speech, and sleep cycle. Hyperammonaemia plays
the important role in the pathogenesis of Hepatic encephalopathy. The brain-blood barrier
disturbances, changes in neurotransmission, neuroinflammation, oxidative stress, and
benzodiazepine pathway abnormalities are considered to be involved in the development of
Hepatic encephalopathy.
- Hepatic encephalopathy has 4 stages wherein it can lead to hepatic coma when left
untreated. High ammonia levels are toxic to the central nervous system which is why hepatic
encephalopathy may further lead to hepatic coma.
Systemic Carnitine Deficiency Guide Questions:
- Systemic Carnitine Deficiency is an autosomal recessive disorder that prevents the body from
utilizing fats for energy production during the fasting state.
- This disorder is caused by a mutation in the SLC22A5 gene wherein this gene is one that
provides instructions for making a protein called OCTN2 that is found in the heart, liver, muscles,
kidneys, and other tissues. This protein is positioned within the cell membrane and it is important
because it transports carnation into the cell. Once this gene is mutated, this can result in the
improper transfer of carnitine across the cell membrane resulting in urinary carnitine wasting
which will lead to a low plasma level of carnitine and decreased intracellular carnitine
accumulation. Hence, it impairs the entry of long-chain fatty acids into the mitochondrial matrix.
According to Li et al, there are approximately half of the missense mutations while the other half
are composed of splice site, nonsense, and deletion or insertion mutations, which results in
dysfunctional OCTN2 gene product and decreased carnitine transport in various tissues.
2. What is the biochemical basis for the outstanding manifestations of patients with SCD?
* During periods of fasting, our body’s predominant source of energy production is fatty acids. In
patients with Systemic Carnitine Deficiency, there is deficient carnitine, thus, it will result in
defective fatty acid oxidation. When fat cannot be utilized, glucose is consumed without
regeneration via gluconeogenesis resulting in hypoglycemia. In addition to that, there will be
released fat from adipose tissue which will result in the accumulation of fats in the liver, skeletal
muscle, and heart resulting in hepatic steatosis and myopathy.